- Retraction Note
- Open Access
- Published:
Retraction Note: The microRNA-1246 promotes metastasis in non-small cell lung cancer by targeting cytoplasmic polyadenylation element-binding protein
Diagnostic Pathology volume 12, Article number: 53 (2017)
Retraction
This article [1] has been retracted by the Editor. Figure 1 (panels: A, C, D, E, F), 2 (panels: A, E, F, G, H) and 4, as well as parts of the text, were duplicated from Tian et al., 2012 [2]. The findings of this study are therefore unreliable. The Editor has been unable to confirm with Southern Medical University whether an institutional investigation has taken place. We have not been able to contact the authors.
References
Huang W, Li H, Luo R. The microRNA-1246 promotes metastasis in non-small cell lung cancer by targeting cytoplasmic polyadenylation element-binding protein 4. Diagn Pathol. 2015 Jul 25;10:127.
Tian Q, Liang L, Ding J, Zha R, Shi H, Wang Q, et al. MicroRNA-550a acts as a pro-metastatic gene and directly targets cytoplasmic polyadenylation element-binding protein 4 in hepatocellular carcinoma. PLoS One. 2012;7(11):e48958.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1186/s13000-015-0366-1
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Huang, W., Li, H. & Luo, R. Retraction Note: The microRNA-1246 promotes metastasis in non-small cell lung cancer by targeting cytoplasmic polyadenylation element-binding protein. Diagn Pathol 12, 53 (2017). https://doi.org/10.1186/s13000-017-0637-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13000-017-0637-0